Gainers & Losers

YOU ARE ON :
  • HOME /
  • IPO /
  • IPO ISSUES /
  • IPO-SYNOPSIS

Alivus Life Sciences Ltd

Registered Office: Plot No. 170-172 Chandramouli,Industrial Est.Mohol Bazarpeth, Solapur - 413213, Maharashtra, India.
Phone : 91-2189-234456/234246   Fax:
Email :  complianceofficer@glenmarklifesciences.com  
Website :  www.glenmarklifesciences.com

Initial public offer of 21,022,222 equity shares of face value of Rs. 2 each ("equity shares") of Glenmark Life Sciences Limited ("Company" or "Issuer") for cash at a price of Rs. 720 per equity share (including a share premium of Rs. 718 per equity share) aggregating to Rs. 1513.60 crores (the "offer") comprising a fresh issue of 14,722,222 equity shares aggregating to Rs. 1060 crores (the "fresh issue") and an offer for sale of up to 6,300,000 equity shares by Glenmark Pharmaceuticals Limited ("Promoter Selling Shareholder") and such equity shares, The "offered shares") aggregating to Rs. 453.60 crores (The "offer for sale"). The offer shall constitute 17.16% of the post-offer paid-up equity share capital of the company. The face value of equity shares is Rs. 2 each. Offer Price : Rs. 720 per Equity Share of face value of Rs. 2 each. Anchor Investor offer price: Rs. 720 per Equity share. The Offer Price is 360 times the face value.

Issue Money Payable On
Opens on Closes On Application Allotment
27-Jul-21 29-Jul-21 720.00-0.00 0.00-0.00
Minimum Application for shares in Nos : 20   Further Multiples of : 20
  Rs(Cr.) Lead Managers to the Issue
Project Cost 1,060.00 BOB Capital Markets Ltd
Project Financed through Current Offer 1,513.60  
Post Issue Equity Share Capital 24.51  
Issue Price 720.00  

Project

  • Payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company pursuant to the Business Purchase agreement
  • Funding capital expenditure requirements
  • General corporate purposes

Promoted By

Glenmark Pharmaceuticals Ltd

Listing At

BSE

NSE

Registrar to the Issue

KFin Techologies Ltd

Attention Investor:

1) "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."         2) For Stock Broking Transaction "Prevent unauthorised transactions in your account Update your mobile numbers / email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile / email at the end of the day .... Issued in the interest of Investors."         3) For Depository Transaction "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....Issued in the interest of investors."         4) No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.